Page last updated: 2024-08-24

triazoles and atl 146e

triazoles has been researched along with atl 146e in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Linden, J; Macdonald, TL; Peirce, SM; Rieger, JM; Skalak, TC1
Duling, BR; Linden, J; Platts, SH1
Day, YJ; Huang, L; Linden, J; Marshall, MA; McDuffie, MJ; Okusa, MD1
Lappas, CM; Linden, J; Rieger, JM1
Linden, J; Marshall, MA; Murphree, LJ; Sullivan, GW1
Ellman, PI; Kern, JA; Kron, IL; Laurent, JJ; Linden, J; Maxey, TS; Okonkwo, DO; Reece, TB; Tache-Leon, C; Tribble, CG1

Other Studies

6 other study(ies) available for triazoles and atl 146e

ArticleYear
Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 281, Issue:1

    Topics: Animals; Cell Line; Cyclohexanecarboxylic Acids; Dermatitis; Drug Combinations; Humans; Ischemia; Leukocytes; Male; Necrosis; Pressure Ulcer; Purines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reference Values; Regional Blood Flow; Reperfusion Injury; Skin; Triazines; Triazoles

2001
Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation.
    American journal of physiology. Heart and circulatory physiology, 2003, Volume: 284, Issue:6

    Topics: Animals; Arterioles; Biotransformation; Capillaries; Cyclohexanecarboxylic Acids; Erythrocytes; Glycocalyx; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Receptor, Adenosine A2A; Reperfusion Injury; Triazines; Triazoles

2003
Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction.
    American journal of physiology. Gastrointestinal and liver physiology, 2004, Volume: 286, Issue:2

    Topics: Adenosine A2 Receptor Agonists; Animals; Blood Cells; Chemokines; Cyclohexanecarboxylic Acids; Cytokines; Drug Administration Schedule; Edema; Gene Deletion; Ischemia; Leukocytes; Liver; Liver Circulation; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Purines; Radioligand Assay; Receptor, Adenosine A2A; Reperfusion Injury; RNA, Messenger; Triazines; Triazoles

2004
A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells.
    Journal of immunology (Baltimore, Md. : 1950), 2005, Jan-15, Volume: 174, Issue:2

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; CD4-Positive T-Lymphocytes; Cell Line; Cyclic AMP; Cyclohexanecarboxylic Acids; Gene Dosage; Humans; Interferon-gamma; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Purines; Receptor, Adenosine A2A; Receptors, Antigen, T-Cell; RNA, Messenger; Rolipram; Triazines; Triazoles

2005
Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction.
    The Biochemical journal, 2005, Nov-01, Volume: 391, Issue:Pt 3

    Topics: Animals; Cells, Cultured; Cyclohexanecarboxylic Acids; Gene Expression Regulation; Humans; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitriles; Protein Binding; Purines; Receptor, Adenosine A2A; RNA, Messenger; Sulfones; Transcription, Genetic; Triazines; Triazoles; Tumor Necrosis Factor-alpha

2005
Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism.
    Journal of vascular surgery, 2006, Volume: 44, Issue:2

    Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Cell Survival; Cyclohexanecarboxylic Acids; Disease Models, Animal; Microtubule-Associated Proteins; Neurons; Neuroprotective Agents; Paraplegia; Purines; Rabbits; Receptor, Adenosine A2A; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia; Time Factors; Triazines; Triazoles

2006